Reymova F, Sever B, Topalan E, Sevimli-Gur C, Can M, Tuyun A
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006082
PMC: 11859636.
DOI: 10.3390/ph18020270.
Hwang S, Jeon K, Lee H, Moon I, Jung S, Kim S
Elife. 2024; 13.
PMID: 39641248
PMC: 11623927.
DOI: 10.7554/eLife.97051.
Niharika D, Salaria P, Reddy M
Mol Divers. 2024; .
PMID: 39560899
DOI: 10.1007/s11030-024-11026-0.
Heylen R, Cusick N, White T, Owen E, Patenall B, Alm M
RSC Med Chem. 2024; .
PMID: 39281800
PMC: 11391341.
DOI: 10.1039/d4md00378k.
Dudey A, Rigby J, Hughes G, Stephenson G, Storr T, Chantry A
J Enzyme Inhib Med Chem. 2024; 39(1):2394895.
PMID: 39223706
PMC: 11373361.
DOI: 10.1080/14756366.2024.2394895.
Structural basis for CCR6 modulation by allosteric antagonists.
Wasilko D, Gerstenberger B, Farley K, Li W, Alley J, Schnute M
Nat Commun. 2024; 15(1):7574.
PMID: 39217154
PMC: 11365967.
DOI: 10.1038/s41467-024-52045-7.
Insights into structural vaccinology harnessed for universal coronavirus vaccine development.
Lim C, Leow C, Lim H, Kok B, Chuah C, Oliveira J
Clin Exp Vaccine Res. 2024; 13(3):202-217.
PMID: 39144127
PMC: 11319108.
DOI: 10.7774/cevr.2024.13.3.202.
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors.
Zampieri D, Romano M, Fortuna S, Amata E, Dichiara M, Cosentino G
Molecules. 2024; 29(11).
PMID: 38893570
PMC: 11173765.
DOI: 10.3390/molecules29112697.
Development of a novel representation of drug 3D structures and enhancement of the TSR-based method for probing drug and target interactions.
Milon T, Wang Y, Fontenot R, Khajouie P, Villinger F, Raghavan V
Comput Biol Chem. 2024; 112:108117.
PMID: 38852360
PMC: 11390338.
DOI: 10.1016/j.compbiolchem.2024.108117.
Synthesis and Anti- Activity of 3-Cyanopyridine Derivatives.
Slafer B, Dessoy M, de Oliveira R, Mollo M, Lee E, Matheeussen A
ACS Omega. 2024; 9(20):22360-22370.
PMID: 38799347
PMC: 11112591.
DOI: 10.1021/acsomega.4c01919.
Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.
Narendra G, Raju B, Verma H, Kumar M, Jain S, Tung G
RSC Med Chem. 2024; 15(1):309-321.
PMID: 38283216
PMC: 10809718.
DOI: 10.1039/d3md00543g.
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment.
Miciaccia M, Rizzo F, Centonze A, Cavallaro G, Contino M, Armenise D
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38276008
PMC: 10821046.
DOI: 10.3390/ph17010135.
An Exploration of Small Molecules That Bind Human Single-Stranded DNA Binding Protein 1.
Schuurs Z, Martyn A, Soltau C, Beard S, Shah E, Adams M
Biology (Basel). 2023; 12(11).
PMID: 37998004
PMC: 10669474.
DOI: 10.3390/biology12111405.
Drug Repurposing: Insights into Current Advances and Future Applications.
Bhatia T, Sharma S
Curr Med Chem. 2023; 32(3):468-510.
PMID: 37946344
DOI: 10.2174/0109298673266470231023110841.
Alchemical Free Energy Workflows for the Computation of Protein-Ligand Binding Affinities.
Herz A, Kellici T, Morao I, Michel J
Methods Mol Biol. 2023; 2716:241-264.
PMID: 37702943
DOI: 10.1007/978-1-0716-3449-3_11.
Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach.
Arokia Rajan M, Thirunavukkarasu R, Joseph J, Palliyath G, Somarathinam K, Kothandan G
Curr Microbiol. 2023; 80(10):318.
PMID: 37578562
DOI: 10.1007/s00284-023-03422-w.
Insilico Screening of Pentacyclic Triterpenoids against Vascular Dementia Target's.
Roja R, Kalakotla S, Ravula A, Boyina H, Navanita S, Vallika P
Adv Exp Med Biol. 2023; 1423:237-243.
PMID: 37525050
DOI: 10.1007/978-3-031-31978-5_23.
3D QSAR based Virtual Screening of Flavonoids as Acetylcholinesterase Inhibitors.
Andole S, Sd H, Sudhula S, Vislavath L, Boyina H, Gangarapu K
Adv Exp Med Biol. 2023; 1424:233-240.
PMID: 37486499
DOI: 10.1007/978-3-031-31982-2_26.
Discovery of High-Affinity Amyloid Ligands Using a Ligand-Based Virtual Screening Pipeline.
Chisholm T, Mackey M, Hunter C
J Am Chem Soc. 2023; 145(29):15936-15950.
PMID: 37439212
PMC: 10375536.
DOI: 10.1021/jacs.3c03749.
Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5-a]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis.
Monti L, Liu L, Varricchio C, Lucero B, Alle T, Yang W
ChemMedChem. 2023; 18(20):e202300193.
PMID: 37429821
PMC: 10615688.
DOI: 10.1002/cmdc.202300193.